Page last updated: 2024-09-04

desethyloxybutynin and Urinary Incontinence

desethyloxybutynin has been researched along with Urinary Incontinence in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	5 (71.43)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bang, LM; Easthope, SE; Perry, CM	1
Chancellor, M	1
Wagg, A	1
Gupta, SK; Huang, Y; Parker, MH; Reitz, AB; Ryan, RR	1
Haarala, M; Hakonen, T; Kiilholma, P; Kivelä, A; Lukkari, E; Nilsson, CG	1
Gupta, SK; Sathyan, G	1
Hakonen, T; Lehtoranta, K; Lukkari-Lax, E; Tainio, H; Tammela, TL	1

Trials

4 trial(s) available for desethyloxybutynin and Urinary Incontinence

Article	Year
Transdermal oxybutynin: for overactive bladder. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Exanthema; Humans; Mandelic Acids; Middle Aged; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia	2003
Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients. Neurourology and urodynamics, 1997, Volume: 16, Issue:6 Topics: Adult; Aged; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Mandelic Acids; Middle Aged; Osmolar Concentration; Tablets; Urinary Incontinence	1997
Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. Journal of clinical pharmacology, 1999, Volume: 39, Issue:3 Topics: Administration, Oral; Aged; Area Under Curve; Cholinergic Antagonists; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Mandelic Acids; Metabolic Clearance Rate; Middle Aged; Urinary Incontinence; Xerostomia	1999
Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity. Scandinavian journal of urology and nephrology, 2002, Volume: 36, Issue:1 Topics: Administration, Intravesical; Adolescent; Adult; Cholinergic Antagonists; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics	2002

Other Studies

3 other study(ies) available for desethyloxybutynin and Urinary Incontinence

Article	Year
Transdermal oxybutynin. A viewpoint by Michael Chancellor. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Administration, Cutaneous; Delayed-Action Preparations; Erythema; Humans; Mandelic Acids; Pruritus; Urinary Bladder Diseases; Urinary Incontinence	2003
Transdermal oxybutynin. A viewpoint by Adrian Wagg. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Administration, Cutaneous; Adult; Aged; Delayed-Action Preparations; Humans; Mandelic Acids; Skin; Urinary Bladder Diseases; Urinary Incontinence	2003
The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers. Medicinal chemistry (Shariqah (United Arab Emirates)), 2007, Volume: 3, Issue:6 Topics: Humans; Mandelic Acids; Muscarinic Antagonists; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptor, Muscarinic M5; Receptors, Muscarinic; Stereoisomerism; Structure-Activity Relationship; Urinary Incontinence	2007